Global Respiratory Disorders Treatment Market Size, Share, Growth & Trends Analysis Report by 2032
Respiratory Disorders Treatment Market - By Disease(Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF]), By Drug Class (Bronchodilators, Combination Drugs, Immunotherapy, Corticosteroids, Antibiotics, CFTR, Target Therapy, and Immunotherapy), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Route of Administration (Oral, Nasal, and Injectable), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 78.19 Billion | USD 124.45 Billion | 5.3% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
- 2.2. Respiratory Disorders Treatment Market: Snapshot
- Chapter 3. Global Respiratory Disorders Treatment Market– Industry Analysis
- 3.1. Respiratory Disorders Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Humungous application of leukotriene blocking agents in treating asthma due to its proved efficiency and introduction of novel medicines for treating respiratory ailments will aid growth of respiratory disorders treatment market.
- 3.2.2. Surge in cases of lung transplantation in countries such as the U.S. and the UK is likely to augment scope of respiratory disorders treatment market during 2021-2028.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Disease
- 3.4.2. Market attractiveness analysis By Drug Class
- 3.4.3. Market attractiveness analysis By Route of Administration
- 3.4.4. Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Respiratory Disorders Treatment Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Respiratory Disorders Treatment Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Respiratory Disorders Treatment Market– Disease Analysis
- 5.1. Global Respiratory Disorders Treatment Market overview: By Disease
- 5.1.1. Global Respiratory Disorders Treatment Market share, By Disease, 2020 and 2028
- 5.2. Asthma
- 5.2.1. Global Respiratory Disorders Treatment Market by Asthma, 2018–2028(USD Billion)
- 5.3. Chronic Obstructive Pulmonary Disease [COPD]
- 5.3.1. Global Respiratory Disorders Treatment Market by Chronic Obstructive Pulmonary Disease [COPD], 2018–2028(USD Billion)
- 5.4. Lung Cancer
- 5.4.1. Global Respiratory Disorders Treatment Market by Lung Cancer, 2018–2028(USD Billion)
- 5.5. Respiratory Tract Infection
- 5.5.1. Global Respiratory Disorders Treatment Market by Respiratory Tract Infection, 2018–2028(USD Billion)
- 5.6. Cystic Fibrosis [CF]
- 5.6.1. Global Respiratory Disorders Treatment Market by Cystic Fibrosis [CF], 2018–2028(USD Billion)
- 5.7. Allergic Rhinitis
- 5.7.1. Global Respiratory Disorders Treatment Market by Allergic Rhinitis, 2018–2028(USD Billion)
- 5.1. Global Respiratory Disorders Treatment Market overview: By Disease
- Chapter 6. Global Respiratory Disorders Treatment Market– Drug Class Analysis
- 6.1. Global Respiratory Disorders Treatment Market overview: By Drug Class
- 6.1.1. Global Respiratory Disorders Treatment Market share, By Drug Class, 2020 and 2028
- 6.2. Bronchodilators
- 6.2.1. Global Respiratory Disorders Treatment Market by Bronchodilators , 2018–2028(USD Billion)
- 6.3. Corticosteroids
- 6.3.1. Global Respiratory Disorders Treatment Market by Corticosteroids, 2018–2028(USD Billion)
- 6.4. Combination Drugs
- 6.4.1. Global Respiratory Disorders Treatment Market by Combination Drugs, 2018–2028(USD Billion)
- 6.5. Antibiotics
- 6.5.1. Global Respiratory Disorders Treatment Market by Antibiotics, 2018–2028(USD Billion)
- 6.6. Target Therapy
- 6.6.1. Global Respiratory Disorders Treatment Market by Target Therapy, 2018–2028(USD Billion)
- 6.7. Immunotherapy
- 6.7.1. Global Respiratory Disorders Treatment Market by Immunotherapy, 2018–2028(USD Billion)
- 6.8. CFTR
- 6.8.1. Global Respiratory Disorders Treatment Market by CFTR, 2018–2028(USD Billion)
- 6.1. Global Respiratory Disorders Treatment Market overview: By Drug Class
- Chapter 7. Global Respiratory Disorders Treatment Market– Route of Administration Analysis
- 7.1. Global Respiratory Disorders Treatment Market overview: By Route of Administration
- 7.1.1. Global Respiratory Disorders Treatment Market share, By Route of Administration, 2020 and 2028
- 7.2. Oral
- 7.2.1. Global Respiratory Disorders Treatment Market by Oral , 2018–2028(USD Billion)
- 7.3. Nasal
- 7.3.1. Global Respiratory Disorders Treatment Market by Nasal, 2018–2028(USD Billion)
- 7.4. Injectable
- 7.4.1. Global Respiratory Disorders Treatment Market by Injectable, 2018–2028(USD Billion)
- 7.1. Global Respiratory Disorders Treatment Market overview: By Route of Administration
- Chapter 8. Global Respiratory Disorders Treatment Market overview: By Distribution Channel
- 8.1.1. Global Respiratory Disorders Treatment Market share, By Distribution Channel, 2020 and 2028
- 8.2. Hospital Pharmacies
- 8.2.1. Global Respiratory Disorders Treatment Market by Hospital Pharmacies , 2018–2028(USD Billion)
- 8.3. Online Pharmacies
- 8.3.1. Global Respiratory Disorders Treatment Market by Online Pharmacies, 2018–2028(USD Billion)
- 8.4. Retail Pharmacies
- 8.4.1. Global Respiratory Disorders Treatment Market by Retail Pharmacies, 2018–2028(USD Billion)
- Chapter 9. Company Profiles
- 9.1. Mylan N.V.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. GlaxoSmithKline plc
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Novartis AG
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Development
- 9.4. Cipla
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Development
- 9.5. Roche Diagnostics
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Development
- 9.6. AstraZeneca plc
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Development
- 9.7. Sanofi
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Development
- 9.8. Merck & Co., Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Development
- 9.9. Boehringer Ingelheim International GmbH
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Development
- 9.10. Teva Pharmaceutical Industries
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Development
- 9.11. CHIESI Farmaceutici S.p.A
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Development
- 9.12. Vertex Pharmaceuticals Incorporated
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategy
- 9.12.5. Recent Development
- 9.1. Mylan N.V.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Respiratory Disorders Treatment Marketattractiveness, By Disease
6. Global Respiratory Disorders Treatment Marketattractiveness, By Route of Administration
7. Global Respiratory Disorders Treatment Marketattractiveness, By Drug Class
8. Global Respiratory Disorders Treatment Marketattractiveness, By Distribution Channel
9. Global Respiratory Disorders Treatment Marketshare by Disease ,2020 and 2028 (USD Billion)
10. Global Respiratory Disorders Treatment Marketby Asthma, 2018–2028(USD Billion)
11. Global Respiratory Disorders Treatment Marketby Chronic Obstructive Pulmonary Disease [COPD], 2018–2028(USD Billion)
12. Global Respiratory Disorders Treatment Marketby Lung Cancer, 2018–2028(USD Billion)
13. Global Respiratory Disorders Treatment Marketby Respiratory Tract Infection, 2018–2028(USD Billion)
14. Global Respiratory Disorders Treatment Marketby Allergic Rhinitis, 2018–2028(USD Billion)
15. Global Respiratory Disorders Treatment Marketby Cystic Fibrosis [CF],2018–2028(USD Billion)
16. Global Respiratory Disorders Treatment Marketshare by Drug Class ,2020 and 2028 (USD Billion)
17. Global Respiratory Disorders Treatment Marketby Bronchodilators , 2018–2028(USD Billion)
18. Global Respiratory Disorders Treatment Marketby Corticosteroids, 2018–2028(USD Billion)
19. Global Respiratory Disorders Treatment Marketby Combination Drugs, 2018–2028(USD Billion)
20. Global Respiratory Disorders Treatment Marketby Antibiotics, 2018–2028(USD Billion)
21. Global Respiratory Disorders Treatment Marketby Target Therapy, 2018–2028(USD Billion)
22. Global Respiratory Disorders Treatment Marketby CFTR, 2018–2028(USD Billion)
23. Global Respiratory Disorders Treatment Marketby Immunotherapy, 2018–2028(USD Billion)
24. Global Respiratory Disorders Treatment Marketshare by Route of Administration ,2020 and 2028 (USD Billion)
25. Global Respiratory Disorders Treatment Marketby Oral, 2018–2028(USD Billion)
26. Global Respiratory Disorders Treatment Marketby Nasal, 2018–2028(USD Billion)
27. Global Respiratory Disorders Treatment Marketby Injectable, 2018–2028(USD Billion)
28. Global Respiratory Disorders Treatment Marketshare by Distribution Channel ,2020 and 2028 (USD Billion)
29. Global Respiratory Disorders Treatment Marketby Hospital Pharmacies, 2018–2028(USD Billion)
30. Global Respiratory Disorders Treatment Marketby Retail Pharmacies, 2018–2028(USD Billion)
31. Global Respiratory Disorders Treatment Marketby Online Pharmacies, 2018–2028(USD Billion)
32. Global Respiratory Disorders Treatment Marketshare, by Region, 2020 and 2028
33. North America Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
34. Europe Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
35. Asia Pacific Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
36. Latin America Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
37. The Middle East and Africa Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global Respiratory Disorders Treatment Market: snapshot
2. Drivers of the Respiratory Disorders Treatment Market: impact analysis
3. North America Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
4. North America Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
5. North America Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
6. North America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
7. The U.S. Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
8. The U.S. Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
9. The U.S. Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
10. The U.S. Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
11. Rest of North America Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
12. Rest of North America Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
13. Rest of North America Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
14. Rest of North America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
15. Europe Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
16. Europe Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
17. Europe Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
18. Europe Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
19. UK Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
20. UK Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
21. UK Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
22. UK Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
23. France Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
24. France Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
25. France Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
26. France Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
27. Germany Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
28. Germany Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
29. Germany Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
30. Germany Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
31. Rest of Europe Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
32. Rest of Europe Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
33. Rest of Europe Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
34. Rest of Europe Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
35. Asia Pacific Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
36. Asia Pacific Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
37. Asia Pacific Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
38. Asia Pacific Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
39. China Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
40. China Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
41. China Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
42. China Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
43. Japan Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
44. Japan Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
45. Japan Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
46. Japan Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
47. India Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
48. India Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
49. India Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
50. India Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
51. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
52. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
53. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
54. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
55. Latin America Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
56. Latin America Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
57. Latin America Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
58. Latin America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
59. Brazil Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
60. Brazil Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
61. Brazil Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
62. Brazil Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
63. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
64. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
65. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
66. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
67. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
68. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
69. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
70. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
71. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
72. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
73. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
74. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
75. South Africa Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
76. South Africa Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
77. South Africa Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
78. South Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
79. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Disease ,2018–2028(USD Billion)
80. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Drug Class ,2018–2028(USD Billion)
81. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Route of Administration ,2018–2028(USD Billion)
82. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
This treatment manages diseases affecting breathing. It includes medications and respiratory support
The global Respiratory Disorders Treatment market is expected to be driven by the increasing air pollution, smoking prevalence, and aging population. Demand for long-term respiratory care supports market expansion.
According to study, the global Respiratory Disorders Treatment market size was worth around USD 78.19 Billion in 2023 and is predicted to grow to around USD 124.45 Billion By 2032.
The global Respiratory Disorders Treatment market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.3% during the forecast period from 2024-2032.
The global Respiratory Disorders Treatment industry is projected to be challenged by Challenges include long treatment durations and reimbursement pressure.
The Opportunities include asthma and COPD prevalence, biologics development, home respiratory care, and aging population needs will offer significant growth opportunities in the Respiratory Disorders Treatment market.
Biologics and targeted therapies; smart inhalers with adherence tracking; personalized treatment pathways are the emerging trends and innovations impacting the Respiratory Disorders Treatment market.
The global Respiratory Disorders Treatment market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Respiratory Disorders Treatment market are; Mylan N.V., GlaxoSmithKline plc, Novartis AG, Cipla, Roche Diagnostics, AstraZeneca plc, Sanofi, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, CHIESI Farmaceutici S.p.A, and Vertex Pharmaceuticals Incorporated. and others.
The report explores crucial aspects of the Respiratory Disorders Treatment market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
